Prafulla Bhagat Healthcare Provider

I am a Clinical Research Coordinator/ Data Manager and my career has been mostly focused on working in the Healthcare. I am part of a research team working in the Hematology disease group at Albert Einstein Cancer Center from last 2 years. I help with the clinical trial research data to bring new and advanced treatment options for patients diagnosed with cancer including Multiple Myeloma. I think it is an honor and a great privilege to be a part of therapies which gives hope and new lease of life for many patient who constantly strive in their fight against cancer to live a normal healthy life. It makes me happy to see them recovering and I believe together we surely can make a big change. It is a blessing to be able to make a difference to someone’s life. I am so excited to have this opportunity to raise money for MMRF and to be a part of the Road to Victories team. 

This is the first time I am participating in a cycling event and I am really looking forward to the ride in September!

Sorry, there are no posts from this member.
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More